NDC 65250-133
Exparel 13.3 mg per 1 mL injection, suspension, liposomal
On the label: Pacira Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Pacira Pharmaceuticals, Inc. | San Diego, CA, United States | Makes it and tests it | Problems found, fixed voluntarilyMar 25, 2026 · 12 inspections |
Recalls
- Nov 21, 2019 · Class II · Pacira Pharmaceuticals, Inc.
Sub Potent Drug: Out of Specification (OOS)
Lots: Pacira Lot #: 19-5002, Patheon manufacturer Lot #: 098214; Exp. Date: Dec 2019
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bupivacaine: every company that makes it
- Form
- injection, suspension, liposomal, infiltration
- Strength
- 13.3 mg per 1 mL
- Approval
- NDA NDA022496
- On the market since
- Jan 1, 2016
- Package NDCs
65250-133-0465250-133-0965250-133-10- Official label
- DailyMed (National Library of Medicine), updated Dec 12, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?